AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

16.770

-0.980-5.52%

Volume:925.40K

Turnover:15.73M

Market Cap:5.68B

PE:125.26

High:17.740

Open:17.550

Low:16.690

Close:17.750

52wk High:18.320

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:2.16

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.134

EPS(LYR):-0.030

ROE:7.36%

ROA:2.71%

PB:8.30

PE(LYR):-566.27

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Telix's EPS Forecasts Rise Around 9% for Fiscal 2027, Around 21% for Fiscal 2028 After Glioma Drug Approval, Jefferies Says

MT Newswires Live

Australia's Telix Extends Gains After FDA Approval for Brain Cancer Imaging Drug

Telix Pharma CFO Darren Charlton Smith Acquires 2,071 Common Shares for AUD 19,999.58

FDA Approves Telix Brain Cancer Imaging Drug Pixclara for Glioma PET Scans

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/TLX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":16.77,"timestamp":1789519664696,"preClose":17.75,"halted":0,"volume":925398,"delay":0,"changeRate":-0.05521126760563383,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.1338816643624599,"marketStatus":"Trading","change":-0.98,"latestTime":"09-16 10:47:50 AEST","open":17.55,"high":17.74,"low":16.69,"amount":15729772,"amplitude":0.059155,"askPrice":16.77,"askSize":77,"bidPrice":16.76,"bidSize":259,"shortable":3,"etf":0,"ttmEps":0.1338816643624599,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":17.75,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":2.163149,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":17.75,"auctionPrice":17.55,"auctionVolume":24118,"auctionTime":1789516750297,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516750297}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.029615,"volumeRatio":2.163149,"shares":338721355,"dividePrice":0,"high":17.74,"amplitude":0.059155,"preClose":17.75,"low":16.69,"week52Low":8.26,"pbRate":"8.30","psRate":"4.54","week52High":18.32,"institutionHeld":0,"latestPrice":16.77,"committee":0.541667,"eps":0.1338816643624599,"divideRate":0,"volume":925398,"delay":0,"ttmEps":0.1338816643624599,"open":17.55,"prevYearClose":11.2,"prevWeekClose":15.67,"prevMonthClose":15.36,"prevQuarterClose":16.58,"fiveDayClose":16.69,"twentyDayClose":16.84,"sixtyDayClose":15.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667487616","title":"Telix's EPS Forecasts Rise Around 9% for Fiscal 2027, Around 21% for Fiscal 2028 After Glioma Drug Approval, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667487616","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667487616?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:31","pubTimestamp":1789450283,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  earnings per share  forecasts rose by around 9% in fiscal 2027 and around 21% in fiscal 2028 after securing US Food and Drug Administration  approval for its new drug application for Pixclara, according to a Monday note by Jefferies.Major changes to the forecasts include an assumption of US reimbursement approval and the beginning of material US sales from the start of fiscal 2027's second half.Pixclara is an amino acid positron emission tomography  drug for imaging glioma, a type of brain tumor.It is indicated for use with PET to differentiate recurrent or progressive glioma from treatment-related change, in conjunction with other diagnostic evaluations, in adults and paediatric patients one month of age and older.The brokerage assigned a buy rating to Telix with a raised price target of AU$30 per share from AU$29.30.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","BK7067","PET.AU","BK7047"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667961665","title":"Australia's Telix Extends Gains After FDA Approval for Brain Cancer Imaging Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667961665","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667961665?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:20","pubTimestamp":1789449641,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix extends gains after FDA approval for brain cancer imaging drug** Shares of Telix PharmaceuticalsTLX.AXextend gains into another day, rising as much as 11.5% to A$18.22, their hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691827","title":"Telix Pharma CFO Darren Charlton Smith Acquires 2,071 Common Shares for AUD 19,999.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691827","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691827?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:20","pubTimestamp":1789428051,"startTime":"0","endTime":"0","summary":"Telix Pharma CFO Darren Charlton Smith acquires 2,071 common shares for AUD 19,999.58Telix Pharmaceuticals: Group Chief Financial Officer Darren Charlton Smith increased his stake via a purchase of 2,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL487S5l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Telix Pharma CFO Darren Charlton Smith Acquires 2,071 Common Shares for AUD 19,999.58","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667633236","title":"FDA Approves Telix Brain Cancer Imaging Drug Pixclara for Glioma PET Scans","url":"https://stock-news.laohu8.com/highlight/detail?id=2667633236","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667633236?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:32","pubTimestamp":1789338774,"startTime":"0","endTime":"0","summary":"FDA approves Telix brain cancer imaging drug Pixclara for glioma PET scansFDA cleared Telix’s Pixclara, an F-18 PET imaging drug for glioma, marking the first approved FET-PET agent in the US.Label co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nNDLb2FtNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}